Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Bioverativ Therapeutics Inc.
Scientific Title
A Phase 3, Pivotal, Open-label, Multicenter Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion